Literature DB >> 17656263

Monosomy 7 in t(9;22)-negative cells during nilotinib therapy in an imatinib-resistant chronic myeloid leukemia case.

Amer Zeidan, Surabhi Kakati, Barbara Anderson, Maurice Barcos, Meir Wetzler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17656263      PMCID： PMC2717791          DOI： 10.1016/j.cancergencyto.2006.12.011

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN： 0165-4608


× No keyword cloud information.
  9 in total

1.  p73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage.

Authors:  Z M Yuan; H Shioya; T Ishiko; X Sun; J Gu; Y Y Huang; H Lu; S Kharbanda; R Weichselbaum; D Kufe
Journal:  Nature       Date:  1999-06-24       Impact factor: 49.962

2.  Interaction between ATM protein and c-Abl in response to DNA damage.

Authors:  T Shafman; K K Khanna; P Kedar; K Spring; S Kozlov; T Yen; K Hobson; M Gatei; N Zhang; D Watters; M Egerton; Y Shiloh; S Kharbanda; D Kufe; M F Lavin
Journal:  Nature       Date:  1997-05-29       Impact factor: 49.962

3.  Emergence of clonal cytogenetic abnormalities in Ph- cells in some CML patients in cytogenetic remission to imatinib but restoration of polyclonal hematopoiesis in the majority.

Authors:  Thomas Bumm; Christel Müller; Haifa-Kathrin Al-Ali; Knut Krohn; Patricia Shepherd; Erika Schmidt; Sabine Leiblein; Christina Franke; Evelin Hennig; Thomas Friedrich; Reiner Krahl; Dietger Niederwieser; Michael W N Deininger
Journal:  Blood       Date:  2002-10-31       Impact factor: 22.113

Review 4.  Myelodysplastic syndromes and acute leukemia developing after imatinib mesylate therapy for chronic myeloid leukemia.

Authors:  Craig Kovitz; Hagop Kantarjian; Guillermo Garcia-Manero; Lynne V Abruzzo; Jorge Cortes
Journal:  Blood       Date:  2006-06-29       Impact factor: 22.113

5.  Emergence of new clonal abnormalities following interferon-alpha induced complete cytogenetic response in patients with chronic myeloid leukemia: report of three cases.

Authors:  L Fayad; H Kantarjian; S O'Brien; D Seong; M Albitar; M Keating; M Talpaz
Journal:  Leukemia       Date:  1997-05       Impact factor: 11.528

6.  Chronic myeloid leukemia with permanent disappearance of the Ph1 chromosome and development of new clonal subpopulations.

Authors:  A Hagemeijer; E M Smit; B Löwenberg; J Abels
Journal:  Blood       Date:  1979-01       Impact factor: 22.113

7.  Philadelphia-negative clonal hematopoiesis following imatinib therapy in patients with chronic myeloid leukemia: a report of nine cases and analysis of predictive factors.

Authors:  Yulia Lin; Hélène Bruyère; Douglas E Horsman; Tapio Pantzar; Michael J Barnett; Donna E Hogge; Thomas J Nevill; Stephen H Nantel; Heather J Sutherland; Cynthia L Toze; John D Shepherd; Julye C Lavoie; Kevin W Song; Clayton A Smith; Donna L Forrest
Journal:  Cancer Genet Cytogenet       Date:  2006-10-01

8.  Report of 34 patients with clonal chromosomal abnormalities in Philadelphia-negative cells during imatinib treatment of Philadelphia-positive chronic myeloid leukemia.

Authors:  C Terre; V Eclache; P Rousselot; M Imbert; C Charrin; C Gervais; M J Mozziconacci; O Maarek; H Mossafa; N Auger; N Dastugue; P Talmant; J Van den Akker; C Leonard; F N'Guyen Khac; F Mugneret; F Viguié; M Lafage-Pochitaloff; J N Bastie; G L Roux; F Nicolini; F Maloisel; N Vey; G Laurent; C Recher; M Vigier; Y Yacouben; S Giraudier; J P Vernant; B Salles; J Roussi; S Castaigne; V Leymarie; G Flandrin; M Lessard
Journal:  Leukemia       Date:  2004-08       Impact factor: 11.528

9.  Chromosomal abnormalities in Philadelphia chromosome-negative metaphases appearing during imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase.

Authors:  Jorge Medina; Hagop Kantarjian; Moshe Talpaz; Susan O'Brien; Guillermo Garcia-Manero; Francis Giles; Mary Beth Rios; Kimberly Hayes; Jorge Cortes
Journal:  Cancer       Date:  2003-11-01       Impact factor: 6.860
  9 in total
  5 in total

1.  Emergence of abnormal clone with monsomy 7 in Philadelphia negative cells of CML patients treated with tyrosine kinase inhibitors.

Authors:  Monika Ribeiro de Mello Conchon; Israel Bendit; Patricia Ferreira; Walter Lima; Cristina Kumeda; Lucia Dias; Dalton de Alencar Fischer Chamone; Pedro Enrique Dorlhiac-Llacer
Journal:  Int J Hematol       Date:  2008-12-18       Impact factor: 2.490

2.  Transient monosomy 7 in a chronic myelogenous leukemia patient during nilotinib therapy: a case report.

Authors:  Majd D Jawad; Ronald S Go; Rhett P Ketterling; Kebede H Begna; Kaaren K Reichard; Min Shi
Journal:  Clin Case Rep       Date:  2016-02-08

3.  Poor prognosis of chromosome 7 clonal aberrations in Philadelphia-negative metaphases and relevance of potential underlying myelodysplastic features in chronic myeloid leukemia.

Authors:  Audrey Bidet; Stéphanie Dulucq; Thomas Smol; Alice Marceau-Renaut; Stéphane Morisset; Valérie Coiteux; Marie-Pierre Noël-Walter; Franck-Emmanuel Nicolini; Isabelle Tigaud; Isabelle Luquet; Stéphanie Struski; Baptiste Gaillard; Dominique Penther; Sylvie Tondeur; Nathalie Nadal; Eric Hermet; Lauren Véronèse; Delphine Réa; Carine Gervais; Olivier Theisen; Christine Terré; Pascale Cony-Makhoul; Christine Lefebvre; Jean-Baptiste Gaillard; Isabelle Radford; Anne-Laure Vervaeke; Carole Barin; Elise Chapiro; Florence Nguyen-Khac; Gabriel Etienne; Claude Preudhomme; François Xavier Mahon; Catherine Roche-Lestienne
Journal:  Haematologica       Date:  2018-12-20       Impact factor: 9.941

Review 4.  [Myelodysplastic syndrome with Philadelphia negative+8 clonal chromosomal abnormalities after tyrosine kinase inhibitors therapy for chronic myeloid leukemia: a case report and literature].

Authors:  Y Liu; Y Y Zhang; W Han; X H Zhang; X J Huang; L P Xu
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2019-08-14

5.  [Clinical observation of chromosomal abnormalities in Ph negative cells of chronic myeloid leukemia patients treated with tyrosine kinase inhibitors].

Authors:  J Wang; Yanli Zhang; J Zhou; Y L Zu; Z Li; Y P Song
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2016-05-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.